Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Glucagon receptor activation increases thermogenesis and energy expenditure primarily through hepatic and adipose tissue effects
In June 2025, MBX Biosciences In announced it received preliminary feedback from the FDA on its planned Type B pre-IND meeting, supporting the advancement of its EL-22 program in combination with GLP-1 receptor agonists toward a Phase 2 clinical trial
These treatments are guided by licensed clinicians and tailored to your individual goals
The role of DPP-4: Once GLP-1 is released, its action is relatively short-lived due to the rapid breakdown by an enzyme called Dipeptidyl Peptidase-4 (DPP-4)
